Precision Health Clinical Trials
Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19.
Conditions: Health Care Worker Patient Transmission; Receptor Site Alteration; Susceptibility, Disease; Immune Response
Intervention: Diagnostic Test: Susceptibility to infection
Sponsor: Asociacion para el Estudio de las Enfermedades Infecciosas
Recruiting
Intervention: Diagnostic Test: Susceptibility to infection
Sponsor: Asociacion para el Estudio de las Enfermedades Infecciosas
Recruiting
For more information, visit the Study URL.
A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection
Condition: Chronic Hepatitis B
Interventions: Drug: ABI-H2158; Drug: Placebo; Drug: Entecavir (ETV)
Sponsor: Assembly Biosciences
Recruiting
Interventions: Drug: ABI-H2158; Drug: Placebo; Drug: Entecavir (ETV)
Sponsor: Assembly Biosciences
Recruiting
For more information, visit the Study URL.
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
Condition: Metastatic Prostate Cancer
Intervention: Other: Saliva, Blood, or and/or Archival Tumor Tissue Collection and Analysis
Sponsor: Janssen Research & Development, LLC
Recruiting
Intervention: Other: Saliva, Blood, or and/or Archival Tumor Tissue Collection and Analysis
Sponsor: Janssen Research & Development, LLC
Recruiting
For more information, visit the Study URL.
Better Delineation of YY1 Related Phenotype and Epigenetic Signatures.
Condition: YY1 Related Disorder
Intervention: Genetic: Epigenetic signatures
Sponsor: University Hospital, Montpellier
Recruiting
Intervention: Genetic: Epigenetic signatures
Sponsor: University Hospital, Montpellier
Recruiting
For more information, visit the Study URL.
Better Delineation of CDK13 Related Phenotype and Epigenetic Signature.
Conditions: Congenital Heart Defects; Dysmorphic Facial Features and Intellectual Developmental Disorder
Intervention: Genetic: Epigenetic signatures
Sponsor: University Hospital, Montpellier
Recruiting
Intervention: Genetic: Epigenetic signatures
Sponsor: University Hospital, Montpellier
Recruiting
For more information, visit the Study URL.
Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer
Conditions: Metastatic Biliary Tract Carcinoma; Metastatic Colorectal Carcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Metastatic Malignant Digestive System Neoplasm; Metastatic Pancreatic Adenocarcinoma; Stage IV Colorectal Cancer AJCC v7; Stage IV Pancreatic Cancer AJCC v6 and v7; Stage IVA Colorectal Cancer AJCC v7; Stage IVB Colorectal Cancer AJCC v7
Interventions: Drug: Fluorouracil; Drug: Irinotecan Sucrosofate; Other: Laboratory Biomarker Analysis; Drug: Leucovorin Calcium; Drug: Rucaparib
Sponsors: Academic and Community Cancer Research United; National Cancer Institute (NCI)
Recruiting
Interventions: Drug: Fluorouracil; Drug: Irinotecan Sucrosofate; Other: Laboratory Biomarker Analysis; Drug: Leucovorin Calcium; Drug: Rucaparib
Sponsors: Academic and Community Cancer Research United; National Cancer Institute (NCI)
Recruiting
For more information, visit the Study URL.
Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC)
Conditions: Coronavirus Disease 2019 (COVID-19); SARS-CoV-2
Interventions: Procedure: Biological sample collection; Procedure: Data Collection: Clinical Care Assessments
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Benaroya Research Institute; Boston Children’s Hospital
Recruiting
Interventions: Procedure: Biological sample collection; Procedure: Data Collection: Clinical Care Assessments
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Benaroya Research Institute; Boston Children’s Hospital
Recruiting
For more information, visit the Study URL.
NIAID Centralized Sequencing Protocol
Conditions: Atopy; Primary Immunodeficiency; Autoimmunity; Autoinflammation
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Mental Health (NIMH)
Recruiting
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Mental Health (NIMH)
Recruiting
For more information, visit the Study URL.
Eating Disorders Genetics Initiative
Conditions: Anorexia Nervosa; Bulimia Nervosa; Binge-Eating Disorder
Intervention: Other: Eating disorder diagnosis group
Sponsors: University of North Carolina, Chapel Hill; National Institute of Mental Health (NIMH); University of Otago; University of Aarhus; QIMR Berghofer Medical Research Institute
Recruiting
Intervention: Other: Eating disorder diagnosis group
Sponsors: University of North Carolina, Chapel Hill; National Institute of Mental Health (NIMH); University of Otago; University of Aarhus; QIMR Berghofer Medical Research Institute
Recruiting
For more information, visit the Study URL.
Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy
Conditions: Breast Cancer; Breast Neoplasms; Cancer, Breast
Intervention: Diagnostic Test: Genomic Markers (CTC/ctDNA)
Sponsor: Sunnybrook Health Sciences Centre
Recruiting
Intervention: Diagnostic Test: Genomic Markers (CTC/ctDNA)
Sponsor: Sunnybrook Health Sciences Centre
Recruiting
For more information, visit the Study URL.